Investigational Site Number :8040006

Lviv 79013

0 studies enrolling now · 4 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Relapsing Multiple Sclerosis

Studies at this site

• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed